By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Verona Pharma 

Suite 21 - Alpha House
100 Borough High Street
London    SE1 1LB  United Kingdom
Phone: 44-0-20-7863-3300 Fax: 44-0-20-7863-3314



Life Sciences

Company News
Verona Pharma (VRP.L) Receives Regulatory Approval To Commence Phase IIb Clinical Trial Of RPL554 For COPD Maintenance Treatment In Five Countries Across Europe 6/27/2017 12:34:10 PM
Verona Pharma (VRP.L) Appoints Dr. Desiree Luthman As Vice President Of Regulatory Affairs 6/22/2017 11:00:38 AM
Verona Pharma (VRP.L) Initiates U.S. Clinical Pharmacokinetic Study For RPL554 Following Acceptance Of IND Application By FDA 6/5/2017 11:56:09 AM
Verona Pharma (VRP.L) Announces Closing Of Exercise Of Underwriters’ Over-Allotment Option 5/19/2017 7:54:28 AM
Verona Pharma (VRP.L) Announces Closing Of Global Offering 5/3/2017 11:11:55 AM
Verona Pharma (VRP.L) Release: Grant Of Options And RSUs And PDMR Dealings 5/3/2017 10:13:58 AM
Citi Appointed Depositary Bank For Verona Pharma (VRP.L)’s ADR Programme 5/3/2017 5:22:34 AM
Verona Pharma (VRP.L) Announces Pricing Of Global Offering And Approval To List On The NASDAQ Global Market 4/27/2017 10:52:16 AM
Verona Pharma (VRP.L) Plans To Conduct Registered Initial Public Offering In The U.S. 11/23/2016 1:54:34 PM
Verona Pharma (VRP.L) Rakes in $63.3 Million to Help Progress COPD Candidate RPL554 6/21/2016 6:11:21 AM